Insights into fourth generation selective inhibitors of (C797S) EGFR mutation combating non-small cell lung cancer resistance: a critical review

Lung cancer is the second most common cause of morbidity and mortality among cancer types worldwide, with non-small cell lung cancer (NSCLC) representing the majority of most cases. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) are among the most commonly used targeted ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansour, Mostafa A., AboulMagd, Asmaa M., Abbas, Samar H., Abdel-Rahman, Hamdy M., Abdel-Aziz, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2023
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282734/
https://www.ncbi.nlm.nih.gov/pubmed/37350862
http://dx.doi.org/10.1039/d3ra02347h

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282734/
https://www.ncbi.nlm.nih.gov/pubmed/37350862
http://dx.doi.org/10.1039/d3ra02347h

Ejemplares similares